Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

28/07/2017
The government could compel NHS Professionals’ future buyers to return the agency to its ownership, if they fail to provide staff at adequately low margins.
27/07/2017
Families of a quarter of care home residents eligible for free care are being forced to pay top-up fees, a new report from Age UK has revealed.
27/07/2017
Primary Health Properties (PHP) has announced its interim results, showing a 73.7% rise to £44.3 million in IFRS profit before tax.
27/07/2017
Jill Watts is stepping down from her post as BMI Healthcare’s group chief executive.
27/07/2017
Primary care property investor MedicX Fund has raised £27.5 million through the private placement of loan notes.


Beven Brittan


politics

After a dramatic election result, Ploy Radford asks what our new government means for health and social care
Read more


HealthInvestor Events


public-private partnership
Sarah Williams weighs up the public-private partnership models driving change in health and social care
Read more


Christie + Co

HealthInvestor App


charity profile

Waymarks is tackling the more challenging end of the adult learning disabilities sector. Ploy Radford reports
Read more



interview - David McKinney

Real integration of health and care means throwing housing and technology into the bargain too, according to Tunstall's David McKinney. Sarah Williams hears more
Read more



HealthInvestor blog
The outgoing chief inspector of hospitals may not think the NHS necessarily needs more money to do things better, but social care does if it is to help the health service with bed blocking

Click here to view the Editor's blog


HealthInvestor UK catches up with Professor Takanori Shibata and his robotic creation PARO, 15 years after it first entered care homes, to find out how the fluffy seal is advancing care
Managing director at Regard Group
Clare Connell and Henry Hunt of Connell Consulting investigate the implications of the opiate and prescription-only medicines addiction in the UK
Candesic’s Dr Joe Taylor considers the implications of the UK’s shortage of doctors
Waymarks is tackling the more challenging end of the adult learning disabilities sector. Ploy Radford reports

Click here to search all feature articles